They'll raise if they need to in order to meet capital requirements. The current SP won't prevent them from raising.
My thoughts are that they haven't been granted a funding facility because the product is too new. There's no real data on bad debts. The bad debts are only starting to come through now. Lending criteria already starting to tighten. IOU would have to present a robust case to be granted funding imo.
The company will keep ticking along. The opportunity that was afforded last September isn't available at the moment. It's going to be a long wait before anything exciting happens here imo.
- Forums
- ASX - By Stock
- OVT
- $1 Club
$1 Club, page-30481
-
- There are more pages in this discussion • 1,846 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OVT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.005(13.9%) |
Mkt cap ! $83.23M |
Open | High | Low | Value | Volume |
3.5¢ | 4.4¢ | 3.4¢ | $4.062M | 104.3M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1562346 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 390000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1562346 | 0.041 |
8 | 1629950 | 0.040 |
6 | 591369 | 0.039 |
9 | 1690786 | 0.038 |
10 | 960711 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 300000 | 1 |
0.043 | 1762203 | 9 |
0.044 | 2055361 | 13 |
0.045 | 5581165 | 19 |
0.046 | 2957443 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
OVT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online